Chromosome 14-encoded Alzheimer's Disease: Genetic and Clinicopathological Description
Overview
Affiliations
A family of Finnish descent with very-early-onset Alzheimer's disease has been identified. Genetic analysis of this family eliminated the amyloid precursor protein gene as the pathogenic locus, but strongly implicated a locus on chromosome 14q23.4 between D14S52 and D14S55. The early age at onset of the disease (average, 36 years; range, 35-39 years), the rapid progression, and the early and prominent myoclonus, while they appear to be frequent findings in the chromosome 14-encoded form of Alzheimer's disease, raised the clinical suspicion of prion disease. However, sequencing the prion gene-coding region of 2 affected members of the pedigree failed to show any abnormality. Apart from the presence of modest cortical vacuolar change, the pathological features of our index patient appeared typical of Alzheimer's disease with abundant senile plaques immunoreactive with beta-amyloid, but not with prion protein antibodies.
Molecular mechanisms of sulforaphane in Alzheimer's disease: insights from an in-silico study.
Vu G, Nguyen H In Silico Pharmacol. 2024; 12(2):96.
PMID: 39493676 PMC: 11530583. DOI: 10.1007/s40203-024-00267-4.
Almkvist O, Larsson M, Graff C J Alzheimers Dis. 2023; 97(2):587-598.
PMID: 38160354 PMC: 10836570. DOI: 10.3233/JAD-230618.
Almkvist O, Graff C Front Aging Neurosci. 2022; 14:905329.
PMID: 36275006 PMC: 9580215. DOI: 10.3389/fnagi.2022.905329.
Impaired default network functional connectivity in autosomal dominant Alzheimer disease.
Chhatwal J, Schultz A, Johnson K, Benzinger T, Jack Jr C, Ances B Neurology. 2013; 81(8):736-44.
PMID: 23884042 PMC: 3776464. DOI: 10.1212/WNL.0b013e3182a1aafe.
Transgenic animal models of neurodegeneration based on human genetic studies.
Harvey B, Richie C, Hoffer B, Airavaara M J Neural Transm (Vienna). 2010; 118(1):27-45.
PMID: 20931247 PMC: 3084899. DOI: 10.1007/s00702-010-0476-6.